Cell therapy traditionally involves the ingestion or intramuscular injection of cellular tissue preparations from fetal sheep or cattle tissue. For example, animal fetal brain tissue extract may be used to nourish a functionally impaired human brain. Often several fetal tissues are selected and administered simultaneously to recipients according to individual need.
Today, embryonic cellular tissue extracts from porcine (swine) sources are thought to be superior to their older fetal ovine (sheep), bovine (cattle) and swine counterparts, especially if they have not been frozen or dried. Younger embryonic cells are regarded as more vital and adaptable than older fetal cells. They are unlikely to cause allergic reactions which can occur with older fetal cell extracts. Porcine tissue has the advantage of resembling human tissue more so than any other animal source except other primates (apes, monkeys and their relatives), improving chances of desired communicative effects within the human host, at least theoretically. Swine is not known to transmit certain infectious diseases found in ovine and bovine sources. Fresh chilled extracts are also thought more effective within the host than extracts devitalized by freeze drying or other preservation processes. Testing extract samples from batches stored in cold temperatures over time assures safety and sterility.
Theoretically, embryonic tissues provide nourishing materials that recipient tissues incorporate to help optimize function and repair. Following ingestion or injection much of the material is transported by mechanisms within the body to organs which correspond to those same organs in the donor embryo from where the material originated. Thus, embryonic thyroid goes to thyroid and embryonic kidney goes to kidney. Additionally, the embryonic materials, programmed by nature to generate and organize into functionally viable structures, are thought to aid in restoration and normalization of human recipients. Their use has been associated with exciting beneficial outcomes involving anti-aging, revitalization, and organ repair.
Embryonic tissue is particularly suitable for injection as well as it is for ingestion because of its special relationship to the immune system. Embryonic tissue is not recognized as a foreign invader by the immune system of the mother. The immune system of the mother, therefore, does not attack nor destroy the embryo. If this were not so, no embryo would survive the womb, leading to extinction of the species.
Cell therapy has been used to overcome deficits in both genetic and acquired illnesses. Dramatic results may be found, for example, with genetically impaired mongoloid children in terms of improved facial characteristics, performance, coordination and intelligence following cell therapy. Dramatic results may also be found in many acquired conditions ranging from chronic kidney failure to traumatic brain injury.
Embryonic cell therapy is well known for its use in anti-aging regimes. Upon conception we are programmed to generate and organize into fully developed beings. As we mature and pass peak reproductive adulthood the process of disorganization and degeneration begins to predominate, eventually providing room for future generations to take our place. By introducing embryonic tissue into older humans, programming for generation and organization is theoretically in part restored to more youthful levels resulting in rejuvenation of health. Periodic administration of embryonic cell extracts is thought to help maintain youthfulness and prevent premature health decline.
Embryonic cellular extracts differ from stem cells. Extracts contain cellular components, not whole cells, and cannot reproduce. The extracts with active ingredients programmed by Mother Nature for organization and generation, theoretically can affect host cells to become more active. Since embryonic cell extracts may be used to nourish many organs and processes, potential benefits are many.
Embryonic cell extracts are less expensive and more convenient to administer than stem cell injections. Stem cells from sources other than those of the person hosting them, in event they should survive in their new host, are destined to develop the characteristics of their original source as they mature. Such characteristics may be recognized as foreign (non-self) by the immune system of the new host. Maturing stem cells manifesting such foreign characteristics are targeted and destroyed by the new host immune system, unless immune suppressive drugs are used. Autologous stem cells, stem cells derived from tissues of the host, are not likely to be destroyed since they are foreign entities. Technology remains expensive, as stem cell technology still remains in its relative infancy.
Embryonic and fetal organ sources used to nourish the health of corresponding human tissues and organs as well as the whole person include, but are not limited to:
EMBRYONIC AND FETAL ORGAN SOURCES:
Artery Spinal Marrow
Bone marrow Stomach
Gall bladder Veins
Kidney Whole embryo
Mesenchyme ( A loosely organized, mainly mesodermal embryonic tissue that develops into connective and skeletal tissues, including blood and lymph.
Since organs complement one another within the body, combinations of extracts from different organ sources are often used for the purpose of achieving better outcomes more quickly. Extracts are employed in commercially available synergistic combinations for this purpose.
Various forms of therapy have been called cell therapy, while several methods of preparation and administration have been used with different degrees of efficacy. Despite these clouding issues, scientific studies, clinical case reports, and testimonials that lend credence to cell therapy are numerous.
Once known as a European therapy for the rich and famous, including notables such as Winston Churchill, Charlie Chaplin, and Pope Pius XII, cell therapy has become available in other areas of the world, including the United States. Obviously, the therapy is not a vaccination against death. However, the benefits often far outweigh the costs. Cell therapy has become considerably more affordable for more people now than in the past. Embryonic cell therapy has been used to improve overall health in those with various conditions.
HISTORICALLY, CONDITIONS OF THOSE WHO HAVE USED FETAL OR EMBRYONIC “CELL” EXTRACTS INCLUDE:
Outcomes in overall health improvement associated with nourishment provided via fetal or embryonic cell extracts vary from individual to individual. Usage of cell extracts to treat, mitigate and/or prevent disease is not approved by United States governmental agencies inclusive of the FDA. Accordingly, no claims for disease specific indications or therapeutic benefits are made for embryonic and fetal cell extracts.